Found 32 matching trials
Extension Study of Infigratinib in Children With Achondroplasia (ACH) PHASE2 This is a Phase 2, multicenter, open-label, extension (OLE) study to evalua...
Show More Status
Enrolling By Invitation
Location
USCF Benioff Children's Hospital, Oakland
Learn More & Join Trial
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations PHASE1 The phase 1b study is aimed at determining the pediatric recommended phase ...
Show More Location
Lucile Packard Children's Hospital at Stanford University Medical Center
Learn More & Join Trial
BGJ398 for the Treatment of Tumor-Induced Osteomalacia PHASE2 Background:
People with tumor-induced osteomalacia (TIO) have small tumors...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Phase I BLASST-3 Trial PHASE1 The aim of this research is to see whether using a drug that blocks a prote...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia(AOBA Study) PHASE3 This trial will evaluate the efficacy of KK8398 on annualized height veloci...
Show More Location
Aichi Children's Health and Medical Center
Learn More & Join Trial
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) PHASE2 This is a Phase 2, multicenter, randomized, placebo-controlled study to eva...
Show More Location
UCSF Benioff Children's Hospital
Learn More & Join Trial
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies PHASE1 The study will determine the maximum tolerated dose and thus the recommende...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma PHASE2 This is a multi-center, open label, single arm phase II study evaluating BG...
Show More Location
QED Investigative Site
Learn More & Join Trial
Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification PHASE1 To find the highest tolerable dose of infigratinib that can be given in com...
Show More Location
Multiple Locations
Learn More & Join Trial
Infigratinib in Recurrent High-Grade Glioma Patients EARLY_PHASE1 This trial is an open-label, multicenter, Phase 0 trial that will enroll up...
Show More Location
Chandler Regional Medical Center
Learn More & Join Trial